Trademark Overview
On Friday, October 27, 2023, a trademark application was filed for AVIVE+ with the United States Patent and Trademark Office. The USPTO has given the AVIVE+ trademark a serial number of 98243780. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 24, 2024. This trademark is owned by Axogen Corporation. The AVIVE+ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human or animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissues repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and n...
Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material
